SenCelligent Biosciences is a CAR T cell company dedicated to targeting solid tumors. Addressing the challenges associated with these difficult-to-treat cancers, we are reimagining the use of immune cells to harness their cytolytic potential. Our approach focuses on engineering therapeutic cells that can target tumors on demand.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.